R&D Perspectives in viral clearance Since the 1990s, viral clearance (VC) studies have been a critical safety step for biologic drugs.
News UK biotech venture investment remains buoyant in Q2 Venture financing for UK biotechs reached a five-year high in the second quarter of the year, with more than £2 billion raised, says BIA.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
